Feasibility of S-1/CDDP therapy for outpatients with advanced gastric cancer
Rino, Y.; Murakami, H.; Yukawa, N.; Wada, N.; Oshima, T.; Matsuura, H.; Sugano, N.; Arai, H.; Masuda, M.; Imada, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(11): 1829-1831
2009
ISSN/ISBN: 0385-0684 PMID: 19920383 Document Number: 633010
S-1/CDDP combination chemotherapy is conducted in many institutions, but most patients are hospitalized at the time of CDDP administration. We performed S-1/CDDP combination chemotherapy in 15 patients with advanced gastric cancer, and CDDP was administered in the outpatient department for 8 outpatients out of the 15 patients without renal failure or dysfunction. If outpatient chemotherapy can safely perform a regimen based on evidence, it brings about improvement in the QOL of the patient, and there are considerable advantages for economical care delivery. S-1/CDDP combination chemotherapy for outpatients was regarded as feasible with appropriate patient guidance.